Answers are grounded in this paper and cite their sources.
Purpose Veno-arterial ECMO remains the most common mode of extracorporeal support in infants and children, and despite increases in overall ECMO numbers the utilisation of veno-venous ECMO in neonates appears to be decreasing. We report here outcomes of neonatal and paediatric patients managed with veno-venous ECMO via bi-caval cannulae over a 10-year period in a tertiary referral ICU. Methods Retrospective single-centre case series of veno-venous ECMO cases using dual lumen cannulae over a 10-year period at a tertiary referral paediatric hospital with a low volume ECMO program. Results In the 10-year period 2013–2022, 33 patients required ECMO with 23 receiving veno-arterial ECMO and 10 managed with veno-venous cannulation - 8 with bi-caval cannulae and 2 with multi-site cannulation. Overall survival was 23/33 (69.6%) and in the veno-venous group survival was 7/10 (70%). Median oxygenation index prior to veno-venous cannulation in the 8 patients undergoing bi-caval cannulation was 48 (range 34–54) and median PaO2 was 42 mmHg (range 34–59 mmHg). Duration of ECMO ranged from 7 to 14 days (median 9 days). Complications included migration of the cannula into the hepatic vein, minor and major bleeding, and compromised blood flow secondary to pneumomediastinum. Conclusions Veno-venous ECMO can be reliably established via a single bi-caval cannula in the majority of patients. Outcomes in this small series from a low volume centre are broadly comparable to those reported from the ELSO database.
No takes yet. Share an insight, caveat, or question.
Numa et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: